EN DE
STOCK COMPARISON

Rossi Residencial S.A vs DR Horton: Fair Value & Quality

Both stocks run through our valuation models. Here is how Rossi Residencial S.A (RSID3) and DR Horton (DHI) compare, as of Aug 26, 2026.

As of Aug 26, 2026, Fair Value Calculator sees DR Horton as the more attractively valued of the two: Rossi Residencial S.A trades at BRL 1.60 versus a fair value of BRL 1.32 (-17%), while DR Horton trades at $151 versus $213 (+41%).
Rossi Residencial S.A
RSID3.SA · BRL · Consumer Discretionary
-17%
upside to fair value
overvalued
PriceBRL 1.60
Fair ValueBRL 1.32
Quality52/100
DR Horton
DHI · USD · Consumer Discretionary
+41%
upside to fair value
undervalued
Price$151
Fair Value$213
Quality65/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Rossi Residencial S.ADR Horton
Valuation
0.4×P/E (TTM)14.4×
0.04×P/S (TTM)1.27×
P/B1.75×
11.5×EV/EBITDA10.6×
PEG1.25×
Dividend yield1.1%
Dividend per share$1.70
Profitability
54%Net margin10%
-187%Operating margin11%
Return on equity13%
4%Return on assets7%
Growth
75%Revenue growth (YoY)-2%
35.1%Avg. growth/yr (3Y)0.8%
19.2%Avg. growth/yr (5Y)11.0%
Balance & size
Debt / equity0.25×
$6MMarket cap$42B
mixedGrowth qualitymixed

Rossi Residencial S.A leads: 6 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Rossi Residencial S.Aof which business quality 49 · market factors 35 DR Hortonof which business quality 65 · market factors 36
ProfitabilityMargins and returns on capital today
56
57
Quality GrowthAre margins and returns improving?
80
18
CashflowEarnings quality: real cash, not paper profit
59
55
Fin. StrengthBalance sheet, leverage, solvency risk
2
83
InvestmentDisciplined investing over empire-building
100
80
Low VolatilityCalm price path (market factor)
60
44
MomentumPrice trend over the last 3–12 months (market factor)
28
34
52W MomentumDistance to the 52-week high (market factor)
17
32
Net IssuanceBuybacks instead of dilution
24
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Rossi Residencial S.A

DCF ModelsBRL 0.96
Earnings-BasedBRL 4.51
Dividend DiscountBRL 0.29
MultiplesBRL 1.02
Growth DCFBRL 0.09
Growth EarningsBRL 5.99

11 of 19 models see the stock below the current price.

DR Horton

DCF Models$273
Earnings-Based$181
Dividend Discount$30.70
Multiples$198
Asset-Based$57.15
Growth DCF$237
Economic Profit$136
Growth Earnings$273

7 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Rossi Residencial S.A
Bear BRL 0.84Fair Value BRL 1.32Bull BRL 1.81
BRL 1.60 = current price (white tick)
DR Horton
Bear $128Fair Value $213Bull $277
$151 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Rossi Residencial S.A · Consumer Discretionary

Quality score52 · below median
Fair value upside-17% · below median

DR Horton · Consumer Discretionary

Quality score65 · Top 25%
Fair value upside+41% · Top 25%

Bottom line

As of Aug 26, 2026, Fair Value Calculator sees DR Horton as the more attractively valued of the two: Rossi Residencial S.A trades at BRL 1.60 versus a fair value of BRL 1.32 (-17%), while DR Horton trades at $151 versus $213 (+41%).

DR Horton has the higher quality score (65/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.